newsfilter
← Latest News
ACCESS Newswire·

Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain

Enhanced Brain Biodistribution of GLP-1 Drugs May Be Related to Improvements in Safety and Efficacy KELOWNA, BC / ACCESS Newswire / September 19, 2025 / Lexaria Bioscience Corp. (the